The Dedham Group
Overview
US market access strategy consultancy founded in 2010, focused on oncology and specialty therapeutics. Services include payer and provider access strategy, clinical pathways strategy, and specialty channel strategy.
Notable
Founding brand of Norstella (launched May 2022) alongside Citeline, Evaluate, MMIT, and Panalgo.
Key services
- Oncology/specialty access strategy
- Clinical pathways strategy
- Channel strategy
- Patient support strategy
Subcategories
Verified Reviews
No verified reviews yet — are you a customer of The Dedham Group? Share your experience in a short, confidential interview.
Share your experience